Políticas Médicas

Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.

Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.

Tabla de Políticas Médicas

ID Título Revisión Descripción Acceso
11.003.006 Pruebas Genéticas para el Tratamiento Helico Bacter Pylori May 2026 Helicobacter pylori is a bacterium associated with a number of gastrointestinal problems, such as peptic... Ver
11.003.008 Cytochrome P450 Genotype-Guided Treatment Strategy Jul 2025 The cytochrome p450 (cyp450) family is involved in the metabolism of many currently administered drugs, and... Ver
11.003.009 Molecular Analysis For Targeted Therapy Of Non-Small-Cell Lung Cancer Dec 2025 Over half of patients with non-small-cell lung cancer (nsclc) present with advanced and therefore incurable... Ver
11.003.010 Genetic Testing Of Cadasil Syndrome Jun 2025 Variants in the notch3 gene have been causally associated with cerebral autosomal dominant arteriopathy with... Ver
11.003.011 Genetic Testing To Select Melanoma Or Glioma Patients For Targeted Therapy Jul 2025 The identification of specific, targetable oncogenic “driver mutations” in a subset of melanomas... Ver
11.003.012 Genetic Testing For Inherited Thrombophilia May 2026 Inherited thrombophilias are a group of disorders that predispose individuals to thrombosis. genetic testing... Ver
11.003.013 Genetic Testing For Rett Syndrome Jul 2024 Rett syndrome (rtt), a neurodevelopmental disorder, is usually caused by pathogenic variants in the... Ver
11.003.014 Noninvasive Fetal Rhd Genotyping Using Cell-Free Fetal Dna Sep 2025 Rhesus d (rhd)-negative women who are exposed to rhd-positive red blood cells can develop anti-rhd... Ver
11.003.015 Gene Expression Profile Testing And Circulating Tumor Dna Testing For Predicting Recurrence In Colon Cancer Sep 2024 Gene expression profile (gep) and circulating tumor dna (ctdna) tests have been developed for use as... Ver
11.003.016 Genetic Testing For Pten Hamartoma Tumor Syndrome Mar 2026 The pten hamartoma tumor syndrome (phts) includes several syndromes with heterogeneous clinical symptoms,... Ver
11.003.017 Genetic Testing For Hereditary Hearing Loss May 2026 Hearing loss is a common birth defect. approximately 1 in 500 newborns in developed countries is affected by... Ver
11.003.018 Chromosomal Microarray Testing For The Evaluation Of Pregnancy Loss Sep 2025 Chromosomal microarray (cma) testing of fetal tissue or placental tissue derived from the fetal genotype has... Ver
11.003.020 Genetic Testing For Lactase Insufficiency Jul 2024 Genetic testing of adults with suspected lactase insufficiency is proposed as an alternative to current... Ver
11.003.021 Gene Expression Testing In The Evaluation Of Patients With Stable Ischemic Heart Disease Apr 2021 Expression levels of various genes in circulating white blood cells or whole blood samples have been reported... Ver
11.003.022 Genetic Testing For Li-Fraumeni Syndrome Feb 2026 Li-fraumeni syndrome (lfs) is a cancer predisposition syndrome associated with the development of several... Ver
11.003.023 General Approach To Evaluating The Utility Of Genetic Panels Jan 2026 Genetic panel testing offers potential advantages and disadvantages compared with direct sequence analysis.... Ver
11.003.025 Genetic Testing For Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, And Congenital Anomalies Nov 2025 Chromosomal microarray (cma) testing has been proposed for the detection of genetic imbalances in infants or... Ver
11.003.026 Comprehensive Genomic Profiling for Selecting Targeted Cancer Therapies Nov 2025 Comprehensive genetic profiling offers the potential to evaluate a large number of genetic markers at a... Ver
11.003.027 Gene Variants Associated With Breast Cancer In Individuals At High Breast Cancer Risk. Feb 2026 It is estimated that 3% to 5% of women presenting for assessment for hereditary breast/ovarian cancer risk... Ver
11.003.028 Genetic Testing For Lynch Syndrome And Other Inherited Colon Cancer Syndromes Oct 2025 Genetic testing is available for both those with and those at risk for various types of hereditary cancer.... Ver